# Nuclide record nct07052214 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct07052214/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct07052214", "NCT07052214" ;
  schema:name "PSMA PET Combined With MRI for the Detection of PCa"@en ;
  schema:alternateName "BiPASS"@en ;
  schema:description "A phase 3 trial of Gallium-68 gozetotide in prostate cancer, run by Telix Pharmaceuticals (Innovations) Pty Limited, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct07052214/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07052214> ;
  nuclide:status "recruiting" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:drugs <https://nuclide.cc/drugs/ga68-psma-11/> ;
  nuclide:companies <https://nuclide.cc/companies/telix/> .